Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.
Alessio GasperettiRichard T CarrickSarah CostaPaolo CompagnucciLaurens P BosmanMonica ChivulescuCrystal TichnellBrittney MurrayHarikrishna TandriRafik TadrosLena RivardMaarten P van den BergKatja ZeppenfeldArthur A M WildeGiulio PompilioCorrado CarbucicchioAntonio Dello RussoMichela CasellaAnneli SvenssonCorinna B Brunckhorstvan J Peter TintelenPyotr G PlatonovKristina Hermann HaugaaFirat DuruAnneline S J M Te RielePaul KhairyClaudio TondoHugh CalkinsCynthia A JamesArdan Muammer SagunerJulia Cadrin-TourignyPublished in: Circulation (2022)
PVS significantly improved risk stratification above and beyond the calculator-predicted risk of VA in a primary prevention cohort of patients with ARVC, mainly for patients considered to be at low and intermediate risk by the clinical risk calculator.